Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Association of typical versus atypical antipsychotics with symptoms and quality of life in schizophrenia.

Fujimaki K, Takahashi T, Morinobu S.

PLoS One. 2012;7(5):e37087. doi: 10.1371/journal.pone.0037087. Epub 2012 May 16.

2.

Predictors of quality of life in inpatients with schizophrenia.

Fujimaki K, Morinobu S, Yamashita H, Takahashi T, Yamawaki S.

Psychiatry Res. 2012 May 30;197(3):199-205. doi: 10.1016/j.psychres.2011.10.023. Epub 2012 Feb 26.

PMID:
22370148
3.

Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.

Kitajima R, Miyamoto S, Tenjin T, Ojima K, Ogino S, Miyake N, Fujiwara K, Funamoto Y, Arai J, Tsukahara S, Ito Y, Tadokoro M, Anai K, Kaneda Y, Yamaguchi N.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):300-6. doi: 10.1016/j.pnpbp.2011.11.008. Epub 2011 Nov 21.

PMID:
22122880
4.

Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.

Bervoets C, Morrens M, Vansteelandt K, Kok F, de Patoul A, Halkin V, Pitsi D, Constant E, Peuskens J, Sabbe B.

CNS Drugs. 2012 Nov;26(11):975-82. doi: 10.1007/s40263-012-0003-4. Erratum in: CNS Drugs. 2012 Nov;26(11):1011-2.

PMID:
23018547
5.

Predictors of subjective and objective quality of life in outpatients with schizophrenia.

Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T.

Psychiatry Clin Neurosci. 2008 Aug;62(4):404-11. doi: 10.1111/j.1440-1819.2008.01818.x.

6.

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.

Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG.

Arch Gen Psychiatry. 1997 Jun;54(6):549-57.

PMID:
9193196
7.

Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study.

Alvarez E, Bobes J, Gómez JC, Sacristán JA, Cañas F, Carrasco JL, Gascón J, Gibert J, Gutiérrez M; EUROPA Study Group.

Eur Neuropsychopharmacol. 2003 Jan;13(1):39-48.

PMID:
12480121
8.

Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.

Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):360-70. Epub 2007 Jul 14.

PMID:
17629731
9.

Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.

Ichioka S, Terao T, Hoaki N, Matsushita T, Hoaki T.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):170-4. doi: 10.1016/j.pnpbp.2012.06.008. Epub 2012 Jun 30.

PMID:
22750309
10.

Impact of a switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia.

Kaneda Y, Kawamura I, Fujii A, Ohmori T.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):135-40.

PMID:
15159697
12.

Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.

Gebhardt S, Härtling F, Hanke M, Theisen FM, von Georgi R, Grant P, Mittendorf M, Martin M, Fleischhaker C, Schulz E, Remschmidt H.

Eur Child Adolesc Psychiatry. 2008 Feb;17(1):44-53. Epub 2007 Sep 14.

PMID:
17876506
13.
14.
15.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
16.

Schizophrenia Quality of Life Scale: validation of the Japanese version.

Kaneda Y, Imakura A, Fujii A, Ohmori T.

Psychiatry Res. 2002 Dec 15;113(1-2):107-13.

PMID:
12467950
17.
18.

Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.

Fujikawa M, Togo T, Yoshimi A, Fujita J, Nomoto M, Kamijo A, Amagai T, Uchikado H, Katsuse O, Hosojima H, Sakura Y, Furusho R, Suda A, Yamaguchi T, Hori T, Kamada A, Kondo T, Ito M, Odawara T, Hirayasu Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):755-60. doi: 10.1016/j.pnpbp.2007.12.002. Epub 2007 Dec 14.

PMID:
18226436
19.
20.

Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs.

Mauri MC, Moliterno D, Rossattini M, Colasanti A.

Schizophr Res. 2008 Feb;99(1-3):7-12. Epub 2007 Dec 4.

PMID:
18055177
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk